• Skip to main content
  • Skip to footer

Delphi Diagnostics

Delphi Diagnostics guides personalized breast cancer therapy decisions with the Endocrine Activity Index

  • Technology
    • Lead Inventor
    • Endocrine Activity Index
    • Intellectual Property
  • Our Mission
  • Our Company
    • Board of Directors
    • Executive Team
    • Advisory Board
    • Trusted Collaborators
  • News
  • Contact Us
Home » Our Company » Executive Team » Winz Casagrande

Winz Casagrande

Winz Casagrande, Dr. jur., lic.oec.HSG, ICD.D is Founder, CEO and Chair of Delphi Diagnostics Inc.(R), a breast cancer diagnostic company. She has successfully led the organization’s commercialization from inception through several capital raises.

Winz is an experienced entrepreneur, executive, and Board Director with a passion for building and growing innovative, sustainable enterprises. She is recognized as an expert in governance and has a track record of building highly motivated teams and raising capital for leading-edge, mission-driven enterprises, drawing from an extensive international network.

Winz is a breast cancer survivor.

  • Education: Institute of Corporate Directors (ICD.D), University of Hannover Germany (Dr.jur.), University of St. Gallen (lic.oec. HSG)
  • Boards: Park Lawn Corporation (TSX: PLC): Director and committee member (Governance, Audit, Compensation); RESCo Lease: Chair.
  • Executive: Royal Bank of Canada Dexia: Global Head of Market and Product Strategy; Ernst & Young Canada: National Director Real Estate.

Connect on LinkedIn

Footer

Join us on:

  • LinkedIn
  • Privacy Policy
  • Contact Us
  • News

Copyright © 2025 · Delphi Diagnostics, Inc.™ All rights reserved.